Clinical Significance of Monitoring Circulating Free DNA and Plasma Heat Shock Protein 90alpha in Patients with Esophageal Squamous Cell Carcinoma

References

• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. doi:10.3322/caac.2126225651787
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Abnet CC, Arnold M, Wei WQ. Epidemiology of esophageal squamous cell carcinoma. Gastroenterology. 2018;154(2):360–373. doi:10.1053/j.gastro.2017.08.02328823862
   PubMed Web of Science ®Google Scholar
• Pennathur A, Gibson MK, Jobe BA, et al. Oesophageal carcinoma. Lancet. 2013;381(9864):400–412. doi:10.1016/S0140-6736(12)60643-623374478
   PubMed Web of Science ®Google Scholar
• Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349(23):2241–2252.14657432
   PubMed Web of Science ®Google Scholar
• Domper Arnal MJ, Ferrandez Arenas A, Lanas Arbeloa A. Esophageal cancer: risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol. 2015;21(26):7933–7943.26185366
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhu Z, Liu Y, et al. Diagnostic value of multiple tumor markers for patients with esophageal carcinoma. PLoS One. 2015;10(2):e0116951.25693076
   PubMed Web of Science ®Google Scholar
• He Z, Liu Z, Liu M, et al. Efficacy of endoscopic screening for esophageal cancer in China (ESECC): design and preliminary results of a population-based randomised controlled trial. Gut. 2019;68(2):198–206.29306867
   PubMed Web of Science ®Google Scholar
• Li J, Xu R, Liu M, et al. Lugol chromoendoscopy detects esophageal dysplasia with low levels of sensitivity in a high-risk region of China. Clin Gastroenterol Hepatol. 2018;16(10):1585–1592.29174712
   PubMed Web of Science ®Google Scholar
• Lagergren J, Smyth EC, Cunningham D, Lagergren P, Oesophageal cancer. Nat Rev Dis Primers. 2017;3:17048.28748917
   PubMed Web of Science ®Google Scholar
• Fareed KR, Kaye P, Soomro IN, et al. Biomarkers of response to therapy in oesophago-gastric cancer. Gut. 2009;58(1):127–143. doi:10.1136/gut.2008.15586119091831
   PubMed Web of Science ®Google Scholar
• Pantel K, Alix-Panabieres C. Circulating tumour cells in cancer patients: challenges and perspectives. Trends Mol Med. 2010;16(9):398–406. doi:10.1016/j.molmed.2010.07.00120667783
   PubMed Web of Science ®Google Scholar
• Pantel K, Alix-Panabieres C. Liquid biopsy and minimal residual disease - latest advances and implications for cure. Nat Rev Clin Oncol. 2019;16(7):409–424. doi:10.1038/s41571-019-0187-330796368
   PubMed Web of Science ®Google Scholar
• Kilgour E, Rothwell DG, Brady G, et al. Liquid biopsy-based biomarkers of treatment response and resistance. Cancer Cell. 2020;37(4):485–495. doi:10.1016/j.ccell.2020.03.01232289272
   PubMed Web of Science ®Google Scholar
• Stroun M, Maurice P, Vasioukhin V, et al. The origin and mechanism of circulating DNA. Ann N Y Acad Sci. 2000;906:161–168. doi:10.1111/j.1749-6632.2000.tb06608.x10818614
   PubMed Web of Science ®Google Scholar
• Salvianti F, Giuliani C, Petrone L, et al. Integrity and quantity of total cell-free DNA in the diagnosis of thyroid cancer: correlation with cytological classification. Int J Mol Sci. 2017;18(7):1350. doi:10.3390/ijms18071350
   PubMed Web of Science ®Google Scholar
• Tissot C, Toffart A-C, Villar S, et al. Circulating free DNA concentration is an independent prognostic biomarker in lung cancer. Eur Respir J. 2015;46(6):1773–1780. doi:10.1183/13993003.00676-201526493785
   PubMed Web of Science ®Google Scholar
• Hao TB, Shi W, Shen XJ, et al. Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer. Br J Cancer. 2014;111(8):1482–1489. doi:10.1038/bjc.2014.47025157833
   PubMed Web of Science ®Google Scholar
• Steffensen KD, Madsen CV, Andersen RF, Waldstrøm M, Adimi P, Jakobsen A. Prognostic importance of cell-free DNA in chemotherapy resistant ovarian cancer treated with bevacizumab. Eur J Cancer. 2014;50(15):2611–2618. doi:10.1016/j.ejca.2014.06.02225087181
   PubMed Web of Science ®Google Scholar
• Goodall J, Mateo J, Yuan W, et al. Circulating cell-free DNA to guide prostate cancer treatment with PARP inhibition. Cancer Discov. 2017;7(9):1006–1017. doi:10.1158/2159-8290.CD-17-026128450425
   PubMed Web of Science ®Google Scholar
• Wang X, Song X, Zhuo W, et al. The regulatory mechanism of Hsp90alpha secretion and its function in tumor malignancy. Proc Natl Acad Sci U S A. 2009;106(50):21288–21293. doi:10.1073/pnas.090815110619965370
   PubMed Web of Science ®Google Scholar
• Frydman J. Folding of newly translated proteins in vivo: the role of molecular chaperones. Annu Rev Biochem. 2001;70(1):603–647. doi:10.1146/annurev.biochem.70.1.60311395418
   PubMed Web of Science ®Google Scholar
• Eustace BK, Sakurai T, Stewart JK, et al. Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasiveness. Nat Cell Biol. 2004;6(6):507–514. doi:10.1038/ncb113115146192
   PubMed Web of Science ®Google Scholar
• Shi Y, Liu X, Lou J, et al. Plasma levels of heat shock protein 90 alpha associated with lung cancer development and treatment responses. Clin Cancer Res. 2014;20(23):6016–6022. doi:10.1158/1078-0432.CCR-14-017425316816
   PubMed Web of Science ®Google Scholar
• Fu Y, Xu X, Huang D, et al. Plasma heat shock protein 90alpha as a biomarker for the diagnosis of liver cancer: an official, large-scale, and multicenter clinical trial. EBioMedicine. 2017;24:56–63. doi:10.1016/j.ebiom.2017.09.00728939487
   PubMed Web of Science ®Google Scholar
• Simbolo M, Gottardi M, Corbo V, et al. DNA qualification workflow for next generation sequencing of histopathological samples. PLoS One. 2013;8(6):e62692. doi:10.1371/journal.pone.006269223762227
   PubMed Web of Science ®Google Scholar
• Umetani N, Giuliano AE, Hiramatsu SH, et al. Prediction of breast tumor progression by integrity of free circulating DNA in serum. J Clin Oncol. 2006;24(26):4270–4276. doi:10.1200/JCO.2006.05.949316963729
   PubMed Web of Science ®Google Scholar
• Richter K, Buchner J. Hsp90: chaperoning signal transduction. J Cell Physiol. 2001;188(3):281–290. doi:10.1002/jcp.113111473354
   PubMed Web of Science ®Google Scholar
• Young JC, Moarefi I, Hartl FU. Hsp90: a specialized but essential protein-folding tool. J Cell Biol. 2001;154(2):267–273. doi:10.1083/jcb.20010407911470816
   PubMed Web of Science ®Google Scholar
• Xu Y, Lindquist S. Heat-shock protein hsp90 governs the activity of pp60v-src kinase. Proc Natl Acad Sci U S A. 1993;90(15):7074–7078. doi:10.1073/pnas.90.15.70747688470
   PubMed Web of Science ®Google Scholar
• Xu Y, Singer MA, Lindquist S. Maturation of the tyrosine kinase c-src as a kinase and as a substrate depends on the molecular chaperone Hsp90. Proc Natl Acad Sci U S A. 1999;96(1):109–114. doi:10.1073/pnas.96.1.1099874780
   PubMed Web of Science ®Google Scholar
• Pratt WB. The role of heat shock proteins in regulating the function, folding, and trafficking of the glucocorticoid receptor. J Biol Chem. 1993;268(29):21455–21458. doi:10.1016/S0021-9258(20)80556-08407992
   PubMed Web of Science ®Google Scholar
• Ferrarini M, Heltai S, Zocchi MR, et al. Unusual expression and localization of heat-shock proteins in human tumor cells. Int J Cancer. 1992;51(4):613–619. doi:10.1002/ijc.29105104181601523
   PubMed Web of Science ®Google Scholar
• Wong DS, Jay DG. Emerging roles of extracellular Hsp90 in cancer. Adv Cancer Res. 2016;129:141–163.26916004
   PubMed Web of Science ®Google Scholar